Joaquín
Mosquera Martínez
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Reina Sofia (2)
2020
-
Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment
Lung Cancer, Vol. 150, pp. 90-96
-
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
The Lancet Oncology, Vol. 21, Núm. 5, pp. 645-654